Literature DB >> 33831095

Active screening of patients with diabetes mellitus for pulmonary tuberculosis in a tertiary care hospital in Sri Lanka.

Sumudu Hewage1, Noel Somasundaram2, Vithiya Ratnasamy2, Ishara Ranathunga2, Amitha Fernando1, Indika Perera3, Udara Perera4, Dhammika Vidanagama5, Mizaya Cader1, Poorna Fernando4, Nirupa Pallewatte1, Lakmal Rathnayaka1, Dushani Jayawardhana1, Manjula Danansuriya6, Nalika Gunawardena6.   

Abstract

End TB strategy by the WHO suggest active screening of high-risk populations for tuberculosis (TB) to improve case detection. Present study generates evidence for the effectiveness of screening patients with diabetes mellitus (DM) for Pulmonary TB (PTB). A study was conducted among 4548 systematically recruited patients over 45 years attending DM clinic at the National Hospital of Sri Lanka. The study units followed an algorithm specifying TB symptom and risk factor screening for all, followed by investigations and clinical assessments for those indicated. Bacteriologically confirmed or clinically diagnosed PTB were presented as proportions with 95% CI. Mean (SD) age was 62·5 (29·1) years. Among patients who completed all indicated steps of algorithm, 3500 (76·9%) were investigated and 127 (2·8%) underwent clinical assessment. Proportion of bacteriologically confirmed PTB patients was 0·1% (n = 6,95%CI = 0·0-0·3%). None were detected clinically. Analysis revealed PTB detection rates among males aged ≥60 years with HbA1c ≥ 8 to be 0·4% (n = 2, 95%CI = 0·0-1·4%). The study concludes that active screening for PTB among all DM patients at clinic settings in Sri Lanka, to be non-effective measure to enhance TB case finding. However, the sub-category of diabetic males with uncontrolled diabetics who are over 60 years of age is recommended as an option to consider for active screening for PTB.

Entities:  

Year:  2021        PMID: 33831095     DOI: 10.1371/journal.pone.0249787

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  4 in total

1.  The Footprint of Diabetes Mellitus on the Characteristics and Response to Anti-Tuberculous Therapy in Patients with Pulmonary Tuberculosis from Saudi Arabia.

Authors:  Rania Abd El-Hamid El-Kady; Safaa Abdulrahman Turkistani
Journal:  Infect Drug Resist       Date:  2021-12-10       Impact factor: 4.003

2.  The co-management of tuberculosis-diabetes co-morbidities in Indonesia under the National Tuberculosis Control Program: results from a cross-sectional study from 2017 to 2019.

Authors:  Weixi Jiang; Fauziah Mauly Rahman; Adik Wibowo; Adhi Sanjaya; Permata Imani Ima Silitonga; Shenglan Tang; Qian Long
Journal:  BMC Public Health       Date:  2022-04-08       Impact factor: 3.295

Review 3.  Implementation of the WHO's collaborative framework for the management of tuberculosis and diabetes: a scoping review.

Authors:  Rita Suhuyini Salifu; Mbuzeleni Hlongwa; Khumbulani Hlongwana
Journal:  BMJ Open       Date:  2021-11-17       Impact factor: 3.006

4.  The yield of chest X-ray based versus symptom-based screening among patients with diabetes mellitus in public health facilities in Addis Ababa, Ethiopia.

Authors:  Degu Jerene; Chaltu Muleta; Solomon Dressie; Abdurezak Ahmed; Getahun Tarekegn; Tewodros Haile; Ahmed Bedru; Gidado Mustapha; Agnes Gebhard; Fraser Wares
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2022-10-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.